Drug Profile
AKR 203
Alternative Names: AKR-203Latest Information Update: 13 Apr 2016
Price :
$50
*
At a glance
- Originator Akron Molecules
- Class Analgesics; Anti-inflammatories; Small molecules
- Mechanism of Action Enzyme inhibitors; Purinergic receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Pain
Most Recent Events
- 13 Apr 2016 No development reported - Phase-I for Pain in Austria (PO)
- 16 Oct 2013 Phase-I clinical trials in Pain in Austria (PO) before October 2013